Global Amniotic Products Market Top Major Players 2024, Forecast To 2033
8 Mar, 2024
The amniotic products market size has grown strongly in recent years. It will grow from $0.9 billion in 2023 to $0.98 billion in 2024 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to rising prevalence of burn injuries, increasing demand for regenerative medicine, growing adoption of amniotic products in surgical wounds, rising awareness of amniotic products as a viable treatment avenue, global expansion of amniotic products. The amniotic products market size is expected to see strong growth in the next few years. It will grow to $1.37 billion in 2028 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing patient preference for non-invasive therapies, rising prevalence of chronic wounds, collaborations and partnerships, impact of covid-19, rising prevalence of ophthalmic disorders, increasing healthcare expenditure. Major trends in the forecast period include continuous evolution of product technology, strong growth potential, regional dynamics, impact of covid-19 and a looming global recession, growth in the target patient population, emerging economies.
Global Amniotic Products Market Key Driver
The rising number of trauma and accident cases, exemplified by the significant number of accidents reported in India and the United States in 2021 according to the Ministry of the Road Transport and Highways and the National Highway Traffic Safety Administration respectively, is expected to drive the growth of the amniotic products market. Amniotic products are utilized in treating third-degree burn injuries resulting from trauma, providing effective wound dressing made from a hyper-dry human amniotic membrane.
Get A Free Sample Of The Global Amniotic Products Market ReportGlobal Amniotic Products Market Segments
The amniotic products market covered in this report is segmented –
1) Type:Amniotic Membranes, Amniotic Suspensions
2) Application:Wound Care, Orthopedics, Ophthalmology, Other Applications
3) End-Use:Hospitals And Ambulatory Surgical Centers, Other End Users
By Geography: The countries covered in the amniotic products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
North America was the largest region in the amniotic products market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the amniotic products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Major Amniotic Products Industry Players
Stryker Corporation; Smith & Nephew plc; Integra LifeSciences Holdings Corporation; Lucina BioSciences LLC; Bioventus LLC; Organogenesis Inc.; Alphatec Spine Inc.; MiMedx Group; HMP Global; AlloSource; Orthofix US LLC; ACell Inc.; Aziyo Biologics Inc.; TissueTech Inc.; Amino Technology LLC; LifeCell International Pvt. Ltd.; Tissue Regenix Group plc; Aroa Biosurgery Limited; Skye Biologics Inc.; Celularity Inc.; Sanuwave Health Inc.; NuVision Biotherapies Ltd.; VIVEX Biologics Inc.; Labtician Ophthalmics Inc.; Genesis Biologics Inc.; Applied Biologics LLC; Katena Products Inc.; Next Biosciences; Surgenex LLC; Ventris Medical LLC
Get The Full Global Amniotic Products Market Report
Amniotic Products Market Overview
Amniotic products refer to ortho-biologic products and involve using amniotic-derived products, such as amniotic membrane and fluid products, to enhance joint inflammation and healing. Administration of amniotic products at the injury site helps recovery by stimulating tissue growth.